Vermillion Posts $431K in Q1 Revenue, Anticipates Two Peer-Reviewed Articles on OVA1

The papers, one of which was published this week online, have been accepted for publication in the June edition of Obstetrics & Gynecology and could be key to driving increased adoption of the test by physicians, said Laura Havrilesky, a gynecological oncologist at Duke University.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.